Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001360746 | SCV001556680 | uncertain significance | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11 | 2022-10-13 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RAPSN protein function. ClinVar contains an entry for this variant (Variation ID: 1052540). This variant has not been reported in the literature in individuals affected with RAPSN-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 11 of the RAPSN protein (p.Glu11Asp). |
Revvity Omics, |
RCV003136024 | SCV003813719 | uncertain significance | not provided | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826002 | SCV002089179 | uncertain significance | Congenital myasthenic syndrome | 2020-01-31 | no assertion criteria provided | clinical testing |